3m earnings release, July 21, 2026
3M Reports Second-Quarter 2026 Results; Increases Full-Year Guidance
• Q2 GAAP sales of $6.5 billion, up 2.4%; operating margin of 15.1%, down 290 bps; EPS of $1.78, up 33%, all YoY
◦ Adjusted sales of $6.5 billion with organic growth of 5.4% YoY
◦ Adjusted operating margin of 24.9%, up 40 bps YoY
◦ Adjusted EPS of $2.40, up 11% YoY
• Q2 operating cash flow of $1.0 billion with adjusted free cash flow of $1.3 billion
• 2026 adjusted EPS guidance increased from $8.50 - $8.70 to $8.80 - $8.95
ST. PAUL, Minn. – July 21, 2026 − 3M (NYSE: MMM) today reported second-quarter results.
“We delivered a strong second quarter, exceeding expectations with mid-single-digit sales growth, robust operating margins of about 25%, and double-digit EPS growth, reflecting the progress we’re making on our strategic priorities and building a higher-performing company,” said William Brown, 3M Chairman and CEO. “As a result of our strong first-half performance and continued momentum, we are increasing our full-year guidance and remain confident in our ability to create long-term value for shareholders. I want to thank the 3M team for their disciplined execution, dedication, and relentless focus on delivering innovative solutions for our customers.”
Second-quarter highlights:
• GAAP EPS of $1.78 and operating margin of 15.1%.
• Adjusted EPS of $2.40, up 11% year-on-year.
• Adjusted operating income margin of 24.9%, an increase of 40 basis points year-on-year.
• Sales of $6.5 billion, up 2.4% year-on-year with organic sales up 2.3% year-on-year.
• Adjusted sales of $6.5 billion, up 5.5% year-on-year with adjusted organic sales up 5.4% year-on-year.
• 3M returned $1.4 billion to shareholders via dividends and share repurchases.
• Cash from operations of $1.0 billion.
• Adjusted free cash flow of $1.3 billion.¹
Strategic and operational highlights
The following are recently announced highlights:
• 3M and Microsoft announced a strategic partnership to advance AI data center infrastructure and enterprise transformation. Microsoft becomes the first announced hyperscale cloud provider to deploy 3M Expanded Beam Optics (EBO) technology. Microsoft is a member of the EBO Multi-Source Agreement (MSA) which 3M helped establish to support standardization and broader industry adoption of EBO technology.
• 3M and Airbus signed a long-term agreement to deliver advanced insulation technologies for the A220, improving cabin comfort while supporting aircraft performance and efficiency.
• 3M has entered a multi‑year global partnership as the Cadillac Formula 1® Team’s Official Material Science Partner, leveraging advanced materials, manufacturing and testing to accelerate car development, enhance performance and streamline operations in one of the most demanding racing environments.
• 3M launched Ask 3M, an AI digital assistant powered by AWS that gives customers fast, self-service access to technical expertise, enabling more efficient evaluation of materials, product comparisons, and resolution of application challenges.
• As a part of NASA’s Artemis II mission, the crew of the Orion capsule used 3M™ PELTOR™ ComTac™ VI Tactical Headsets for communication. These headsets are designed to enable communication in extreme environments and are one way 3M is supporting next-generation space exploration.
Updated full-year 2026 guidance¹
3M updated its full-year 2026 guidance given the company’s performance in the first half of the year.
• Adjusted total sales growth² of >4.5 percent, reflecting adjusted organic sales growth² of >3.5 percent.
• Adjusted operating income margin expansion² of 70 bps to 80 bps.
• Adjusted EPS² in the range of $8.80 to $8.95.
• Adjusted operating cash flow² of $5.8 to $6.0 billion, contributing to >100 percent adjusted free cash flow conversion².¹
Guidance does not yet reflect the acquisition of Madison Fire & Rescue, which closed on July 1, 2026.²
As further discussed at⁵ within the "Supplemental Financial Information Non-GAAP Measures" sections, 3M cannot, without unreasonable effort, forecast certain items required to develop meaningful comparable GAAP financial measures and, therefore, does not provide them on a forward-looking basis reflecting these items.
Conference call
3M will conduct an investor teleconference at 9 a.m. ET (8 a.m. CT) today. Investors can access this conference via the following:
• Live webcast at https://investors.3M.com
• Webcast replay at https://investors.3m.com/financials/quarterly-earnings²
Financial statements
Income Statement
Second-quarter highlights:
| Q2 2026 | Q2 2025 | ||
|---|---|---|---|
| GAAP EPS | 1.78 | 1.34 | |
| Special items: | Loss on business divestitures | 0.61 | |
| Special items: | (Increase) decrease in value of Solventum ownership | -0.6 | 0.01 |
| Special items: | Net costs for significant litigation and PFAS exit | 0.44 | 0.79 |
| Special items: | Transformation costs | 0.15 | |
| Special items: | Business acquisition-related costs | 0.02 | |
| Special items: | Manufactured PFAS products | 0.02 | |
| Special items: | Adjusted EPS | 2.4 | 2.16 |
| Memo: | GAAP operating income margin | 15.1 | 18 |
| Memo: | Adjusted operating income margin | 24.9 | 24.5 |
Income Statement
Three months ended June 30, — (Unaudited)
| Three months ended June 30, – 2026 | Three months ended June 30, – 2025 | Six months ended June 30, – 2026 | Six months ended June 30, – 2025 | ||
|---|---|---|---|---|---|
| Net sales | 6,500 | 6,344 | 12,530 | 12,298 | |
| Operating expenses | Cost of sales | 3,817 | 3,646 | 7,391 | 7,124 |
| Operating expenses | Selling, general and administrative expenses | 1,061 | 1,267 | 1,805 | 2,212 |
| Operating expenses | Research, development and related expenses | 302 | 288 | 610 | 573 |
| Operating expenses | Loss on business divestitures | 336 | 3 | 343 | 3 |
| Operating expenses | Total operating expenses | 5,516 | 5,204 | 10,149 | 9,912 |
| Operating expenses | Operating income | 984 | 1,140 | 2,381 | 2,386 |
| Operating expenses | Other expense (income), net | -136 | 217 | 383 | 78 |
| Operating expenses | Income before income taxes | 1,120 | 923 | 1,998 | 2,308 |
| Operating expenses | Provision for income taxes | 183 | 245 | 404 | 510 |
| Operating expenses | Income of consolidated group | 937 | 678 | 1,594 | 1,798 |
| Operating expenses | Income from unconsolidated subsidiaries, net of taxes | 1 | 47 | 3 | 49 |
| Operating expenses | Net income including noncontrolling interest | 938 | 725 | 1,597 | 1,847 |
| Operating expenses | Less: net income attributable to noncontrolling interest | 5 | 2 | 11 | 8 |
| Operating expenses | Net income attributable to 3M | 933 | 723 | 1,586 | 1,839 |
| Earnings per share attributable to 3M common shareholders: | Weighted average 3M common shares outstanding — basic | 519.7 | 537.4 | 524.4 | 540.6 |
| Earnings per share attributable to 3M common shareholders: | Earnings per share — basic | 1.79 | 1.35 | 3.02 | 3.4 |
| Earnings per share attributable to 3M common shareholders: | Weighted average 3M common shares outstanding — diluted | 522.4 | 540.6 | 527.6 | 544.2 |
| Earnings per share attributable to 3M common shareholders: | Earnings per share — diluted | 1.78 | 1.34 | 3.01 | 3.38 |
Income Statement
Three months ended June 30, — (Unaudited) (in millions)
| Three months ended June 30, | Three months ended June 30, | Six months ended June 30, | Six months ended June 30, | ||
|---|---|---|---|---|---|
| Safety and Industrial | 859 | 738 | 1,635 | 1,437 | |
| Transportation and Electronics | 503 | 479 | 902 | 869 | |
| Consumer | 252 | 268 | 469 | 487 | |
| Total reportable business segments | 1,614 | 1,485 | 3,006 | 2,793 | |
| Corporate | Corporate-level (expense) income | 1 | 22 | 35 | 72 |
| Corporate special items: | Net costs for significant litigation and PFAS exit | -183 | -347 | -13 | -421 |
| Corporate special items: | Business acquisition-related costs | -12 | -12 | ||
| Corporate special items: | (Loss) gain on business divestitures | -336 | -3 | -343 | -3 |
| Corporate special items: | Manufactured PFAS products | -17 | -126 | -55 | |
| Corporate special items: | Transformation costs | -100 | -166 | ||
| Corporate special items: | Total Corporate | -630 | -345 | -625 | -407 |
| Corporate special items: | Total Company operating income | 984 | 1,140 | 2,381 | 2,386 |
| Corporate special items: | Other expense/(income), net | -136 | 217 | 383 | 78 |
| Corporate special items: | Income before income taxes | 1,120 | 923 | 1,998 | 2,308 |
Income Statement
Three months ended June 30, 2026 — Certain amounts adjusted for special items (non-GAAP measures): (Dollars in millions, except per share amounts)
| Three months ended June 30, 2026 | Three months ended June 30, 2026 | Three months ended June 30, 2026 | Three months ended June 30, 2026 | Three months ended June 30, 2026 | Three months ended June 30, 2026 | Three months ended June 30, 2026 | Three months ended June 30, 2026 | Three months ended June 30, 2026 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Total Company GAAP amounts | 984 | 15.1 | (290) bps | 1,120 | 183 | 16.3 | 933 | 1.78 | 33 | |
| Corporate GAAP amounts | -630 | |||||||||
| Adjustments for special items: | Net costs for significant litigation and PFAS exit | 183 | 296 | 64 | 232 | 0.44 | ||||
| Adjustments for special items: | Business acquisition-related costs | 12 | 12 | 12 | 0.02 | |||||
| Adjustments for special items: | Loss on business divestitures | 336 | 336 | 20 | 316 | 0.61 | ||||
| Adjustments for special items: | Solventum ownership - change in value | -303 | 11 | -314 | -0.6 | |||||
| Adjustments for special items: | Transformation costs | 100 | 100 | 24 | 76 | 0.15 | ||||
| Adjustments for special items: | Total special items | 631 | 441 | 119 | 322 | 0.62 | ||||
| Adjustments for special items: | Total Company adjusted amounts (non-GAAP measures)4 | 1,615 | 24.9 | 40 bps | 1,561 | 302 | 19.3 | 1,255 | 2.4 | 11 |
| Adjustments for special items: | Corporate adjusted amounts (non-GAAP measures)4 | 1 |
Income Statement
(Unaudited)
| 2026 forecast | ||
|---|---|---|
| 2026 adjusted operating income margin expansion (non-GAAP measure)4,5 | 2026 adjusted earnings per share (non-GAAP measure)4,5 | $8.80 to $8.95 |
| 2026 adjusted operating income margin expansion (non-GAAP measure)4,5 | 2026 adjusted effective tax rate (non-GAAP measure)4,5 | ~20% |
Balance Sheet
June 30, 2026 — (Unaudited)
| June 30, 2026 | December 31, 2025 | ||
|---|---|---|---|
| Current assets | Cash and cash equivalents | 2,955 | 5,235 |
| Current assets | Marketable securities | 375 | 698 |
| Current assets | Accounts receivable – net | 3,927 | 3,533 |
| Current assets | Inventories | 3,770 | 3,661 |
| Current assets | Prepaids | 492 | 391 |
Cash Flow
Six months ended June 30, — (Unaudited)
| Six months ended June 30, – 2026 | Six months ended June 30, – 2025 | ||
|---|---|---|---|
| Net cash provided by (used in) operating activities | 1,560 | -1,033 | |
| Cash flows from investing activities: | Purchases of property, plant and equipment | -448 | -444 |
| Cash flows from investing activities: | Purchases and proceeds from sale or maturities of marketable securities and investments – net | 328 | 1,711 |
| Cash flows from investing activities: | Proceeds from (payments for) sale of businesses, net of cash sold | -326 | 5 |
| Cash flows from investing activities: | Other investing activities | 23 | 18 |
| Cash flows from investing activities: | Net cash provided by (used in) investing activities | -423 | 1,290 |
| Cash flows from financing activities: | Change in debt – net | -151 | |
| Cash flows from financing activities: | Purchases of treasury stock and dividends paid to shareholders | -3,806 | -3,013 |
| Cash flows from financing activities: | Proceeds from issuances of treasury stock pursuant to stock option and benefit plans | 364 | 988 |
| Cash flows from financing activities: | Other financing activities | -16 | -15 |
| Cash flows from financing activities: | Net cash provided by (used in) financing activities | -3,458 | -2,191 |
| Cash flows from financing activities: | Effect of exchange rate changes on cash and cash equivalents | -5 | 46 |
| Cash flows from financing activities: | Net increase (decrease) in cash and cash equivalents, including cash classified within assets held for sale | -2,326 | -1,888 |
| Cash flows from financing activities: | Less: net increase (decrease) in cash classified within assets held for sale | -46 | |
| Cash flows from financing activities: | Net increase (decrease) in cash and cash equivalents | -2,280 | -1,888 |
| Cash flows from financing activities: | Cash and cash equivalents at beginning of year | 5,235 | 5,600 |
| Cash flows from financing activities: | Cash and cash equivalents at end of period | 2,955 | 3,712 |
Cash Flow
Three months ended June 30, (in millions)
| Three months ended June 30, – 2026 | Three months ended June 30, – 2025 | Six months ended June 30, – 2026 | Six months ended June 30, – 2025 | |
|---|---|---|---|---|
| Net cash provided by (used in) operating activities | 986 | -954 | 1,560 | -1,033 |
| Net cash provided by (used in) investing activities | -483 | 70 | -423 | 1,290 |
| Net cash provided by (used in) financing activities | -1,334 | -1,769 | -3,458 | -2,191 |
Cash Flow
Three months ended June 30, (in millions)
| Three months ended June 30, – 2026 | Three months ended June 30, – 2025 | Six months ended June 30, – 2026 | Six months ended June 30, – 2025 | ||
|---|---|---|---|---|---|
| Net cash provided by (used in) operating activities | 986 | -954 | 1,560 | -1,033 | |
| Adjustments for special items: | Net costs/(recoveries) for significant litigation and PFAS exit after-tax payment impacts | 574 | 2,216 | 683 | 3,003 |
| Adjustments for special items: | Divestiture costs after-tax payment impacts | 43 | 59 | ||
| Adjustments for special items: | TCJA transition tax payment | 211 | 211 | ||
| Adjustments for special items: | Transformation actions after-tax payment impacts | 11 | 43 | ||
| Adjustments for special items: | Manufactured PFAS products after-tax payment impacts | -25 | 51 | -32 | |
| Adjustments for special items: | Total adjustments for special items | 585 | 2,445 | 777 | 3,241 |
| Adjustments for special items: | Adjusted net cash provided by (used in) operating activities (non-GAAP measure)6 | 1,571 | 1,491 | 2,337 | 2,208 |
| Adjustments for special items: | Purchases of property, plant and equipment (PPE) | -223 | -208 | -448 | -444 |
| Adjustments for special items: | Manufactured PFAS products impact - removing related purchases of PPE | 1 | 9 | ||
| Adjustments for special items: | Adjusted purchases of PPE (non-GAAP measure)6 | -223 | -207 | -448 | -435 |
| Adjustments for special items: | Adjusted free cash flow (non-GAAP measure)6 | 1,348 | 1,284 | 1,889 | 1,773 |
| Adjustments for special items: | Adjusted net income attributable to 3M4 | 1,255 | 1,170 | 2,395 | 2,198 |
| Adjustments for special items: | Adjusted free cash flow conversion (non-GAAP measure)6 | 107 | 110 | 79 | 81 |
Cash Flow
(Unaudited) (in billions)
| 2026 forecast | |
|---|---|
| Net cash provided by (used in) operating activities | $5.8 to $6.0 |
| Adjusted net cash provided by (used in) operating activities (non-GAAP measure)5,6 | $5.8 to $6.0 |
| Purchase of property, plant and equipment (PPE) | ~$1.1 |
| Adjusted free cash flow (non-GAAP measure)5,6 | $4.7 to $4.9 |
| Net income attributable to 3M | $4.6 to $4.7 |
| Adjusted net income attributable to 3M (non-GAAP measure)4,5 | $4.6 to $4.7 |
| Adjusted free cash flow conversion (non-GAAP measure)5,6 | >100% |
Full release
Forward-looking statements
Certain statements in this document, as well as other filings we make with the United States Securities and Exchange Commission (“SEC”) and other written and oral information we release are considered "forward-looking statements" under the federal securities laws, including the Private Securities Litigation Reform Act of 1995, as amended ("PSLRA"). Forward-looking statements may appear throughout this document and are typically identified by the words "aim," "anticipate," "believe," "can," "continue," "could," "estimate," "evaluate," "expect," "forecast," "future," "goal," "guidance," "impact," "initial," "intend," "likely," "may," "outlook," "plan," "possible," "potential," "predict," "probable," "project," "seek," "should," "strategy," "target," "will," "would," and other words that are similar to, or have the opposite meanings, of those words.
All forward-looking statements are intended to enjoy the protection of the PSLRA’s safe harbor for forward-looking statements, as well as the protections provided by other securities laws. Forward-looking statements speak only as of the date they are made and the Company assumes no obligation to update or revise any forward-looking statements. Readers are cautioned not to place undue reliance on any of these forward-looking statements.... (truncated)nd expectations of future events and trends that are subject to risks and uncertainties. Changes in those assumptions, expectations, or other factors could produce materially different results. The most important risks, uncertainties, and other factors that could cause the Company's actual results to differ from the Company's forward-looking statements include:(1) worldwide economic, political, regulatory, international trade, geopolitical, tariffs, and retaliatory countermeasures, capital markets, and other external conditions, (2) foreign currency exchange rates and fluctuations in those rates, (3) liabilities and contingencies related to PFAS, including liabilities related to claims, lawsuits, and government regulatory proceedings concerning various PFAS-related products and chemistries, as well as risks related to the Company's exit of PFAS manufacturing and work to discontinue use of PFAS across its product portfolio, (4) risks related to the PWS Settlement to resolve claims by public water suppliers in the United States regarding PFAS, as well as risks related to ongoing PFAS-related settlements and claims, (5) legal proceedings, including significant developments that could occur in the legal and regulatory proceedings described in the Company's reports on Form 10-K, 10-Q, and 8-K, as well as compliance risks related to legal or regulatory requirements, government contract requirements, policies and practices, or other matters that require or encourage the Company or its customers, suppliers, vendors, or channel partners to conduct business in a certain way, (6) competitive conditions and customer preferences, (7) the timing and market acceptance of new product and service offerings, (8) the availability and cost of purchased components, compounds, raw materials and energy due to shortages, increased demand and wages, tariffs, supply chain interruptions, or natural or other disasters, (9) unanticipated problems or delays when implementing new business systems and solutions, including with the phased implementation of a global enterprise resource planning system, or security breaches and other disruptions to the Company's information or operational technology infrastructure, (10) use of artificial intelligence technologies, (11) the impact of acquisitions, strategic alliances, divestitures, and other strategic events resulting from portfolio management actions and other evolving business strategies, (12) operational execution, including the extent to which the Company can realize the benefits of planned productivity improvements, as well as the impact of organizational restructuring activities, (13) financial market risks that may affect the Company's funding obligations under defined benefit pension and postretirement plans, (14) the Company’s credit ratings and its cost of funding, (15) tax-related external conditions, including changes in tax rates, laws, or regulations, (16) matters relating to the Company's Aearo Entities, Combat Arms Earplugs Settlement, and related products, and (17) matters relating to the spin-off of Solventum, the Company's former Health Care business, into an independent public company.
Those risks, uncertainties, and other factors are further described in Part I, Item 1A, "Risk Factors" of the Company's Form 10-K for the year ended December 31, 2025. For additional information concerning factors that may cause actual results to differ materially from the Company's forward-looking statements, see the Company's reports on Form 10-K, 10-Q, and 8-K filed with the SEC from time to time.³